We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+17.61%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$10.6B
AUM Growth
+$1.44B
Cap. Flow
+$92.7M
Cap. Flow %
0.88%
Top 10 Hldgs %
22.72%
Holding
2,357
New
64
Increased
127
Reduced
1,296
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Healthcare 12.78%
3 Financials 12.6%
4 Consumer Discretionary 11.75%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIO
2226
DELISTED
City Office REIT
CIO
$99.2K ﹤0.01%
10,150
-2,524
-20% -$20.8K
CTMX icon
2227
CytomX Therapeutics
CTMX
$760M
$98.4K ﹤0.01%
15,026
AMRX icon
2228
Amneal Pharmaceuticals
AMRX
$6.15B
$96K ﹤0.01%
21,017
-13,661
-39% -$60.5K
NAT icon
2229
Nordic American Tanker
NAT
$1.36B
$92K ﹤0.01%
31,192
-8,076
-21% -$26.3K
TRUE
2230
DELISTED
TrueCar
TRUE
$90.7K ﹤0.01%
21,601
-2,718
-11% -$12.1K
OSW icon
2231
OneSpaWorld
OSW
$2.7B
$90.6K ﹤0.01%
8,932
-922
-9% -$7.29K
AKBA icon
2232
Akebia Therapeutics
AKBA
$248M
$89.9K ﹤0.01%
32,096
+3,799
+13% +$11.1K
LOCO icon
2233
El Pollo Loco
LOCO
$463M
$88K ﹤0.01%
4,862
-6,017
-55% -$101K
RBBN icon
2234
Ribbon Communications
RBBN
$372M
$87.9K ﹤0.01%
13,393
+5,843
+77% +$30.9K
SXC icon
2235
SunCoke Energy
SXC
$801M
$87.8K ﹤0.01%
20,181
-22,028
-52% -$92.2K
CBAY
2236
DELISTED
Cymabay Therapeutics
CBAY
$87.8K ﹤0.01%
15,293
-6,111
-29% -$46.3K
MGI
2237
DELISTED
MoneyGram International, Inc. New
MGI
$87.3K ﹤0.01%
+15,980
New +$89.7K
CHRD icon
2238
Chord Energy
CHRD
$7.53B
$87.1K ﹤0.01%
+2,351
New +$69.2K
ARAY icon
2239
Accuray
ARAY
$33.4M
$83.9K ﹤0.01%
+20,127
New +$73.9K
ZIXI
2240
DELISTED
Zix Corporation
ZIXI
$82.5K ﹤0.01%
9,556
+436
+5% +$3.1K
BDSI
2241
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$79.1K ﹤0.01%
18,833
+1,008
+6% +$3.88K
TITN icon
2242
Titan Machinery
TITN
$431M
$75.2K ﹤0.01%
3,844
-5,501
-59% -$94.4K
FMNB icon
2243
Farmers National Banc Corp
FMNB
$957M
$73.8K ﹤0.01%
5,558
-7,856
-59% -$98.2K
MBI icon
2244
MBIA
MBI
$254M
$71.8K ﹤0.01%
10,913
-5,817
-35% -$37.8K
APTS
2245
DELISTED
Preferred Apartment Communities, Inc.
APTS
$71.4K ﹤0.01%
9,647
-6,269
-39% -$42.8K
VRS
2246
DELISTED
Verso Corporation
VRS
$70K ﹤0.01%
5,826
-2,856
-33% -$28.3K
SYRE icon
2247
Spyre Therapeutics
SYRE
$9.18B
$62.9K ﹤0.01%
320
-485
-60% -$101K
ORC
2248
Orchid Island Capital
ORC
$1.32B
$62.3K ﹤0.01%
2,387
-765
-24% -$20.3K
CALA
2249
DELISTED
Calithera Biosciences, Inc
CALA
$61.6K ﹤0.01%
627
+453
+260% +$39.7K
HMHC
2250
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$60.8K ﹤0.01%
18,262
+5,714
+46% +$17K

Similar funds

MetLife Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, MetLife Investment Management held 2,357 positions worth $10.6B, up 16% from $9.13B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q4 2020 filing shows 64 new, 127 increased, 1,296 reduced and 88 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M. The largest sale was Apple, an estimated $23.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2020 buy was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $23M increase.
  • MetLife Investment Management's biggest Q4 2020 reduction was Apple, cutting an estimated $23.3M.
  • MetLife Investment Management fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $3.86M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $10.6B portfolio in Q4 2020.
  • MetLife Investment Management opened 64 new positions and closed 88 in Q4 2020.
  • MetLife Investment Management's portfolio value rose 16% quarter-over-quarter to $10.6B.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.